CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Chr. Hansen

Caroline Herody, Head of Global Regulatory Affairs

How Regulatory has Become Strategically Important to Food and Feed Companies

Caroline Herody

Caroline Herody

Perhaps you have never heard of Chr. Hansen, but chances are you had a bite of us this morning! Founded in 1874, our natural ingredients – good bacteria, probiotics or enzymes – are in every other cheese and yogurt in the world, and we touch the lives of more than one billion people every day. We are present in over 30 countries with 3,700 employees and rank as one of the world’s most sustainable companies.


If you started your career more than 15 years ago, you may remember that most food and feed companies didn’t even have a Regulatory function. Well, now not only most of those companies have created a dedicated department, butwe are invited to provide input to defining the companystrategyand to deciding on whether or not to invest or acquire a new business – Why this transformation?


In the wake of a series of human food and animal feed crises combined with an increasing concern about the risk of consumers being misled, a number of countries decided to initiate substantial reforms of their food law in the early 2000s.  Those set of international, regional and national regulations form a complex system of rules covering the entire food chain, from animal feed and health, through plant protection and food production, to processing, storage, transport, import and export and retail sales.


As outcome-based regulations have been considered appropriate for low to medium risk activities and not high-risk activities such as feeding people and animals, those reforms generally privileged prescriptive regulations which state or describe what must be done and also how work is to be carried out. An increasing number of products entering the food chain have also become subject topre-market approvals based on the assessment of extensive datasets on the identity, safety and efficacy of the product.


In practice, this means that companies operating in the food and feed sector have had to adapt to that fact that conditions for market access of their products have become more demanding and more challenging to implement in their innovation process and supply chain.


Where to play and how to win 


The performance of a Regulatory teamnotonly directly impacts the speed and cost to market of innovations, but also helps mitigatethe risk of market access discontinuity in a context of constant evolution of regulations and standards.


Regulatory is now involved when a company defines it strategy, i.e., when it makes explicit choices on which things to prioritize and then builds a business around those choices.


Regulatory is now involved when a company defines it strategy, i.e., when it makes explicit choices on which things to prioritize and then builds a business around those choices.Where to play represents the set of choices that narrow the competitive field. The questions to be asked focus on where the company will compete— in which markets, with which customers and consumers, through which channels and in which product categories. It could also lead to the decision to acquire or merge with another existing business. The role of Regulatory is to provide insight on the expected time and budget needed to access the selected markets of interest, to estimate the likelihood of success, and also to ensure that coming changes to regulations and standards will not jeopardize access to the market.


How to win defines the choices for winning in that field. It is the recipe for success in the chosen segments, categories, channels, geographies, and so on. It is of utmost importance to anticipate the capabilities, capacity and footprint needed for Regulatory to open the markets within the time and budget forecast in the Strategy.The ability to attractthe best regulatory experts and transforming them into an expert team, combining high level of task-related expertise and the mastering of team processes, will eat your market access strategy for breakfast.


 


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/how-regulatory-has-become-strategically-important-to-food-and-feed-companies-nwid-812.html